Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2024-11-14 3:32 pm Sale | 13G | STANDARD BIOTOOLS INC. LAB | Indaba Capital Management L.P. | 2,641,379 0.700% | -5,333,995 (-66.88%) | View |
2024-11-12 6:01 pm Unchanged | 13G | STANDARD BIOTOOLS INC. LAB | VANGUARD GROUP INC | 17,292,092 4.650% | 0 (Unchanged) | View |
2024-11-08 2:17 pm Unchanged | 13G | STANDARD BIOTOOLS INC. LAB | BlackRock Inc. BLK | 22,452,115 6.000% | 0 (Unchanged) | View |
2024-11-04 1:59 pm Purchase | 13G | STANDARD BIOTOOLS INC. LAB | VANGUARD GROUP INC | 17,292,092 4.650% | 13,158,153 (+318.30%) | View |
2024-10-24 2:02 pm Purchase | 13G | STANDARD BIOTOOLS INC. LAB | BlackRock Inc. BLK | 22,452,115 6.000% | 20,434,905 (+1013.03%) | View |
2024-10-21 4:26 pm Sale | 13G | STANDARD BIOTOOLS INC. LAB | MILLENNIUM MANAGEMENT LLC | 6,984,232 1.900% | -8,052,833 (-53.55%) | View |
2024-08-14 8:54 pm Purchase | 13D | STANDARD BIOTOOLS INC. LAB | Casdin Capital LLC | 73,766,074 19.770% | 3,364,737 (+4.78%) | View |
2024-06-03 5:20 pm Sale | 13D | STANDARD BIOTOOLS INC. LAB | Casdin Capital LLC | 70,401,337 18.910% | -5,936,401 (-7.78%) | View |
2024-05-22 4:54 pm Purchase | 13D | STANDARD BIOTOOLS INC. LAB | Casdin Capital LLC | 76,337,738 20.370% | 1,802,072 (+2.42%) | View |
2024-03-20 6:05 pm Purchase | 13G | STANDARD BIOTOOLS INC. LAB | VIKING GLOBAL INVESTORS LP | 58,651,170 15.300% | 29,544,805 (+101.51%) | View |
2024-03-20 5:25 pm Purchase | 13D | STANDARD BIOTOOLS INC. LAB | Casdin Capital LLC | 74,535,666 19.250% | 9,238,070 (+14.15%) | View |
2024-02-26 4:15 pm Purchase | 13G | STANDARD BIOTOOLS INC. LAB | MILLENNIUM MANAGEMENT LLC | 15,037,065 5.200% | 15,037,065 (New Position) | View |
2024-02-14 3:32 pm Purchase | 13G | STANDARD BIOTOOLS INC. LAB | Indaba Capital Management L.P. | 7,975,374 9.900% | 80,623 (+1.02%) | View |
2024-02-13 5:14 pm Purchase | 13G | STANDARD BIOTOOLS INC. LAB | VANGUARD GROUP INC | 4,133,939 5.210% | 177,971 (+4.50%) | View |
2024-01-12 2:04 pm Purchase | 13D | STANDARD BIOTOOLS INC. LAB | Neuberger Berman Group LLC | 4,382,584 11.000% | 46,481 (+1.07%) | View |
2024-01-09 5:13 pm Purchase | 13D | STANDARD BIOTOOLS INC. LAB | Casdin Capital LLC | 65,297,596 19.710% | 27,715,250 (+73.75%) | View |
2024-01-09 4:46 pm Purchase | 13G | STANDARD BIOTOOLS INC. LAB | VIKING GLOBAL INVESTORS LP | 29,106,365 9.500% | 20,817,249 (+251.14%) | View |
2024-01-08 5:00 pm Sale | 13D | STANDARD BIOTOOLS INC. LAB | Caligan Partners LP | 7,042,413 2.400% | -755,041 (-9.68%) | View |
2023-11-22 4:15 pm Unchanged | 13D | STANDARD BIOTOOLS INC. LAB | VIKING GLOBAL INVESTORS LP | 8,289,116 9.500% | 0 (Unchanged) | View |
2023-10-16 4:30 pm Sale | 13D | STANDARD BIOTOOLS INC. LAB | VIKING GLOBAL INVESTORS LP | 8,289,116 9.500% | -34,705 (-0.42%) | View |